The methylcobalamin form in particular shows nerve-repairing properties, and has been shown to reduce homocysteine levels, treat peripheral neuropathy, ALS, multiple sclerosis, Alzheimer, Bells palsy, and other neurological disorders
In human AML stem cells, BCAT1 is overexpressed, and the BCAA pathway is activated by the low levels of -KG, displaying a DNA hypermethylation phenotype similar to IDH mutant-positive cancers (Raffel et al., 2017)
And the long-term cardiovascular outcomes data that exist for semaglutide, most notably the FLOW and SELECT trials demonstrating reductions in cardiovascular events and kidney disease progression [4, 5], do not yet exist for retatrutide
Highlights of Prescribing Information: Xenical (orlistat) Capsules for oral use